Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
August 21, Thursday 2014 11:47 AM       
       HEADLINES: Execute liquor ban completely, says Hassan                                              What use inspecting closed bars, asks ET                                              Sudheeran seeks ban on liquor completely                                              Traders go on strike in state                                              Gas cylinder lorry strike ends                                              Yoga guru B K S Iyengar passes away                                              Five militants killed in Assam                                              2G case: Bail granted to Dayalu Ammal                                              PM asks DRDO to complete projects in time                                              Islamic State militants behead US journalist, release video                                              Sharif to meet Khan as protesters threaten to storm PM House                                              Shooting well, hope to win Olympic quota in Spain: Gurpal                                              Gujarat boxing body claims conspiracy in suspension                                              Kaumudi Facebook
       BUSINESS Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter  
       Ranbaxy recalls over 64,000 bottles of generic Lipitor in US
 
         Posted on :22:10:56 Mar 8, 2014
   
A A
       Last edited on:22:10:56 Mar 8, 2014
         Tags: Ranbaxy, Lipitor in US
 

NEW DELHI: Drug major Ranbaxy Laboratories has recalled over 64,000 bottles of Atorvastatin calcium tablets, a generic version of cholesterol-lowering drug Lipitor, after a complaint of wrong dosage.

The Indian firm, which is reeling under regulatory action from the US Food and Drug Administration (USFDA), recalled the drug after a complaint by a pharmacist who discovered a 20 mg tablet inside a sealed bottle of Atorvastatin 10 mg tablets.

"Ranbaxy Pharmaceuticals is conducting a voluntary recall in the US limited to two lots of Atorvastatin calcium tablets, 10 mg manufactured in India which expire in May 2014," it said in a statement.

The company, majority owned by Japan's Daiichi Sankyo, said it recalled the tablets "because of a remote possibility of the presence of a 20 mg Atorvastatin calcium tablet in a 10 mg bottle."

"This is the basis of the voluntary recall," it added.

To date, Ranbaxy has not received any product complaints related to these batches, the company said.

"Other lot numbers, package sizes and strengths are not affected by this recall. The recall is being conducted at the retail level," it added.

Ranbaxy is withdrawing the lots out of abundant caution, keeping the safety of patients in mind and with full knowledge of the USFDA, it said.

In January, the USFDA prohibited Ranbaxy from producing and distributing drugs for the American market from its Toansa facility in Punjab.

The Toansa plant catered to over 70 per cent of Ranbaxy's requirement for raw material used in medicine formulations. Toansa was the fourth Ranbaxy plant banned by the USFDA.

In September, the USFDA imposed an import alert on Ranbaxy's Mohali plant in Punjab for violating good manufacturing norms.

Ranbaxy's key facilities at Paonta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh have been under a US import alert since 2008.

A A
       BUSINESS
Next Article: SBI mulls selling bad assets to ARCs in Jan-Mar quarter
 
 
BUSINESS HEADLINES
Diesel can be market-priced by September as crude falls to $100  
Sebi moots stringent norms for timely, adequate disclosures  
Sensex, Nifty touch record highs; auto stocks shine  
Cairn says Rajasthan block holds 1-3 Tcf of gas reserves  
Mercedes to hike prices by up to 2.5% in India from September  
India takes top spot in Nielsen's global consumer confidence  
Low growth, high inflation not acceptable: Jaitley  
Inflation at 5-month low of 5.19 per cent in July  
Finmin to finalise capital raising plan for PSU banks next mth  
Top 5 richest Indians have half of nation's billionaire wealth  
NDA govt will not entertain FDI in multi-brand retail'  
Bimal Jalan to head Expenditure Management Commission  
Companies have to comply with CSR norms: Govt  
Par passes Bill to give teeth to Sebi to tackle ponzi menace  
Sensex zooms 361 points; auto stocks rally  
RBI transfers Rs.52,679 crore profit to government  
Tata Sons-Singapore Airlines JV 'Vistara' set for Oct launch  
Sensex rises for 1st time in 4 sessions; HDFC, M&M lead gains  
Judge rejects $324.5 mln settlement over Apple, Google hiring  
Sensex weighed down by global sentiment, rebound expected  
RBI chief Rajan warns of global market 'crash'  
Sensex tumbles 260 pts on geopolitical tensions, weak Re  
Gold climbs Rs 300 on seasonal buying, firming global cues  
Facebook advertisements now cost more  
RBI to cut down 'pre-emptions' to spur efficiency  
 
Do you think that complete liquor ban is practicable in Kerala?
Yes
 
No
 
Don't Know
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy